menu ☰
menu ˟

FDA approves Siliq for treating psoriasis

16 Feb 2017
The FDA announced today that it has approved Siliq as treatment for moderate-to-severe plaque psoriasis.Siliq (brodalumab, Valeant Pharmaceuticals) is administered by injection and is intended for patients who are candidates for systemic therapy or p...

Click here to view the full article which appeared in

IPH Logo